INTRODUCTION
AS has become the most frequent valvular heart disease and the most frequent cardiovascular disease after hypertension and coronary artery disease in the Western world. The prevalence of AS in the population older than 65 years is between 2-7% and is expected to rise with an aging population. (1) The most common form is primary calcifi c AS, a disease characterised by progressive leafl et calcifi cation and fi brosis that results in left ventricular (LV) outfl ow obstruction with symptom onset in the sixth decade. Once thought to be purely an age-related or degenerative disease, it is now well accepted that this condition is an infl ammatory disease similar to atherosclerosis. When this disease process involves bicuspid aortic valves, patients usually present one to two decades earlier. When the aortic valve is diseased (possibly calcifi ed), but non-obstructive, the term aortic sclerosis is applied. We consider this unwise and prefer to use the term aortic valve disease with minimal or no gradient. Aortic sclerosis is a precursor of calcifi c AS with an average time of progression to severe AS of 8 years. (2) The rate of progression in any individual is unpredictable and labelling patients as "aortic sclerosis" creates a false sense of complacency and comfort.
All patients with clinically detectable aortic valve disease require careful serial monitoring to detect disease progression. The classical teaching is that severe AS causes a small, slowrising pulse, a loud long ejection systolic murmur, a soft or absent second heart sound and systemic hypotension with a reduced pulse pressure. However, not all patients will have these signs.
A combination of a right clavicular murmur and the following signs:
a reduced carotid upstroke; reduced carotid volume; soft second heart sound; and a maximal murmur intensity at the right sternal edge, strongly predicts moderate or severe AS. (3, 4) The classic delayed rise of the pulse can be absent even with severe disease particularly in the elderly population with an inelastic arterial bed. Although hypotension and a low pulse pressure may be signs of AS, a normal blood pressure or even severe hypertension does not exclude AS. Between 22-40% of patients requiring aortic valve replacement have a systolic blood pressure of > 130mmHg. (5, 6) Not all murmurs of AS will radiate to the neck.
The murmur may best be heard at the apex (Gallavardin's phenomenon) and may be confused with mitral regurgitation.
Listening carefully for post-ectopic accentuation of the murmur which occurs with AS, but not with mitral regurgitation, can be a helpful distinguishing feature. It is important to note that when LV dysfunction occurs, the murmur intensity may decrease or disappear completely despite severe valve obstruction or so-called occult AS. The clinician needs to look for other clues for the presence of AS including observing calcifi cation of the aortic valve which is found in nearly all patients > 50 years with severe AS and LV hypertrophy on ECG which is seen in 85% of patients with signifi cant AS.
In the differential diagnosis of AS always consider hypertrophic obstructive cardiomyopathy and congenital sub/supravalvar aortic stenosis in younger patients. is the most reproducible measurement one has to be careful about assessing the severity of AS using velocities or gradients alone. Gradient is infl uenced by stroke volume, systolic ejection time, heart rate, preload, afterload and contractility. As a result gradient can often vary from one time to another. Aortic valve area calculation factors in some of these variables and is less infl uenced by variable haemodynamic states, but is less reproducible and is more prone to errors in measurement. (9) Mild AS 2.6-3.0 m.s Multiple readings need to be taken. 
There is a wide variation in the correlation of symptoms with the severity of AS defi ned by velocity, gradient or valve area.
Generally, symptoms can be attributed to AS if the aortic valve area is < clinical end-points. (16, 17) In theory, ACE inhibition could play a role in preventing pro- 
AS with reduced ejection fraction
Reduced ejection fraction in patients with aortic stenosis can be caused either by the severe afterload or contractile dysfunction.
It is important to differentiate between these two causes as a low ejection fraction caused by severe afterload usually responds to relief of the afterload and has a good prognosis because contractility is maintained and the ejection fraction improves post surgery. The mean transvalvular gradient is a good measure of afterload and, generally, the higher the gradient (mean gradient > 35mmHg), the greater the afterload and usually the better response to surgery. (20) Most of the above patients will be symptomatic. A minority may be asymptomatic and should undergo aortic valve replacement when the LVEF <=50%.
Patients with AS and a reduced ejection fraction caused by contractile dysfunction generally have a poorer response to surgery because irreversible LV dysfunction rather than severe afterload is the cause of the reduced ejection fraction. These patients will typically have a small transvalvar gradient, with a small reduction in afterload and smaller improvement in ejection fraction post surgery. Low-fl ow, low-gradient AS is defi ned as a reduced ejection fraction (LVEF<=40%) and a low gradient (mean gradient < 30mmHg) with a valve area < 1.0cm 2 . As the calculation of valve area in the Gorlin's equation is fl ow dependent, aortic valve area is highly dependent on cardiac output.
As cardiac output can be reduced by any cause of contractile dysfunction, it is important to identify patients with truly severe AS (whose severe valve disease has led to severe LV dysfunction) showed that when contractile reserve was present, 6 year survival after aortic valve replacement was 75%. (22) When contractile reserve was absent, prognosis was much worse, although even some patients without contractile reserve improved post surgery. Methods to identify this latter group of patients whom may benefi t still needs to be identifi ed.
AS in elderly patients
Symptom onset is often diffi cult to determine in the elderly.
Fatigue rather than dyspnoea can be the sign of limited effort tolerance. History should also address patients' wishes and examination should focus on co-morbidities. Coronary angio-
PITFALLS IN AORTIC STENOSIS
Adapted from Bermejo et al. (21) Relative AS Area > 0. There have been many studies to date that have shown that there is almost no age limit for aortic valve surgery in patients with aortic stenosis in the absence of comorbid disease. (23) Operative mortality of aortic valve replacement is approximately 10% in patients over 80 years of age. The decision to operate relies on a team approach (cardiac surgeon, anaesthetist, cardiologist, geriatrician) with an accurate estimation of the risk/benefi t ratio, comorbidity, operative mortality and life expectancy.
AS and regurgitation
Many patients will have a combination of AS and regurgitation.
These patients should be evaluated and managed with standard diagnostic approaches described above. It must be emphasised that symptoms may develop when AS and regurgitation is quantifi ed as "moderate". (24) Aortic valve replacement is clearly indicated in patients who are symptomatic, LV systolic function is <=50%
or at the time of other cardiac surgery.
AS and hypertension
AS and hypertension frequently co-exist in the same patient. 
AS and coronary artery disease
Signifi cant coronary disease occurs in about 30% of preoperative cardiac catheterisation. (24) 
PERCUTANEOUS AORTIC VALVE REPLACEMENT
Percutaneous implantation of an aortic valve seems to offer a durable improvement in valve function at a lower risk than aortic valve replacement. Initial experience has demonstrated the feasibility of this approach in patients with severe co-morbidities and contra-indications to surgery. Growing experience and ongoing trials in patients at high operative risk will allow more accurate evaluation of this procedure.
CONCLUSION
We have attempted to highlight some of the pitfalls in the diagnosis and management of AS. In many instances, the estimation of severity of aortic stenosis and the timing of valve replacement surgery is easy. In older patients and those with concomitant coronary, pulmonary or other disease it may be extraordinarily diffi cult. In truly asymptomatic patients the matter of severity of AS does not usually need to be pursued. In any symptomatic patient, once the possibility of AS has been entertained, investigation needs to be continued until the severity of the AS and its contribution to the symptoms has been clearly established.
